1
JUNE
2021
Waltham, MA - Nova Biomedical announces the addition of another important critical care parameter to its Stat Profile Prime Plus... Details
30
APR
2021
Waltham, MA - Nova Biomedical is pleased to announce the opening of a new sales, service, and distribution subsidiary in Benelux... Details
18
JAN
2021
Waltham, MA - Nova Biomedical announces the addition of a Sample Retain Collector (SRC) for BioProfile FLEX2 cell culture analyzer... Details
1
NOV
2020
Waltham, MA - Nova Biomedical announces the addition of a key new test to its Stat Profile Prime Plus critical care analyzer... Details

Webinars on timely topics such as POCT, critical care, clinical practice and regulatory updates, and common conditions including sepsis and hyperglycemia.
Upcoming | On-Demand

Nova Biomedical develops, manufactures, and sells advanced technology blood testing analyzers. We employ over 1,200 people, with sales and service subsidiaries in eight countries and distributors in more than 91 additional countries. Nova has manufacturing facilities in Waltham and Billerica, Massachusetts; and Taipei, Taiwan. Nova is one of the 25 largest in vitro diagnostic companies in the world and the largest privately owned in vitro diagnostic company in the United States.
Hospital Blood Gas and Critical Care Analyzers
Nova Biomedical is the world technology leader in the development of fast, whole blood analyzers to support the care of hospitalized and critically ill patients. Nova analyzers offer the most extensive stat test menus and deliver results in the shortest time at the lowest costs. Nova also provides handheld meter-and-strip based measuring systems for glucose, ketone, lactate, and creatinine point-of-care testing. Whether testing is performed in the central laboratory or in emergency, surgical, critical, or respiratory care areas, Nova analyzers can help to improve patient outcomes while reducing the cost of care.
Chemistry and Cell Culture Analyzers for Biotechnology
Nova manufactures a series of BioProfile® automated cell culture analyzers for rapid analysis of key nutrients, metabolites, pH, gases, and cell density/cell viability.
Self-Testing Diabetes Meters
Nova develops and manufactures blood glucose meters and test strips for self-testing by patients with diabetes. The glucose meters are distributed under the Nova Max® label in the U.S. and Canada, the Menarini label in Europe and the Walgreen's label in the U.S.
Product Development and Manufacturing for Corporate Partners
In addition to Nova products, we develop and manufacture medical devices and diagnostic products for many of the world’s leading healthcare corporations.
Pioneering Technological Innovations
Nova Biomedical has a 40-year history as the world leader in developing whole blood biosensors for clinical and cell culture/fermentation use.
We practice our core values of mutual respect, honesty, and integrity throughout Nova. With a strong sense of family in the workplace, we are proud that one third of all our employees have been with us for over 10 years.
More info
Search our current listing in any one of the following fields: Sales, Research and Product Development, General Business, Quality and Regulatory Affairs, Technical Support, and Hourly Manufacturing
Nova Biomedical Corporation
200 Prospect Street
Waltham, MA 02454-9141 USA
Telephone: 781-894-0800
Fax: 781-899-6259
E-mail: info@novabiomedical.com